rsharp has no upcoming events.
rsharp has not provided any information.
The concept of "personalised medicine" has been knocking around the pharmas and regulators for years now without making much progress. To move forward we must disambiguate the term "personalised".
I think pain is interesting id DMD - because I think there is a fundemental relationship between pain and dystrophin.
Lobbying for Exon skipping as a platform drug.
rsharp has added no photos to their photo roll.